SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-20-000245
Filing Date
2020-01-03
Accepted
2020-01-03 18:02:34
Documents
2
Period of Report
2020-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 4985
2 EXHIBIT 24 ex24.htm EX-24 3373
  Complete submission text file 0001140361-20-000245.txt   10064
Mailing Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019
Business Address 9 WEST 57TH STREET 41ST FLOOR NEW YORK NY 10019 212-230-9742
KKR Group Partnership L.P. (Reporting) CIK: 0001472698 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38959 | Film No.: 20507207

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations